Key Action
In terms of Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has issued physical letters to shareholders whose email addresses are not registered with the company or their Depository Participants.
Purpose of Communication
The letters provide the web-link and path to access the Annual Report for the financial year 2025-26, which includes the Notice of the 47th AGM.
AGM Details
The 47th Annual General Meeting is scheduled to be held on Friday, September 18, 2026, at 03:30 P.M. (IST) through Video Conferencing (VC) / Other Audio-Visual Means (OAVM).
Web Access Information
The web-link provided to shareholders is: https://www.jagsonpal.com/annual-report/
The specified path is: https://www.jagsonpal.com/annual-report/ > Jagsonpal Pharmaceuticals Limited > Investor Relation > Annual Report 2026
Additional Information
The notice dated July 29, 2026, convening the AGM contains detailed information about:
- Procedure for e-voting
- Participation at the AGM
- Speaker registration
- Dividend information